Molecular therapy for Human Cancer: Roquin [RING finger and CCCH-type zinc finger domain-containing protein 1] increases the expression of tumor suppressor PDCD4 via down regulation of its target gene, 8/March/2015, 22.34

Molecular therapy for Human Cancer: Roquin [RING finger and CCCH-type zinc finger domain-containing protein 1] increases the expression of tumor suppressor PDCD4 via down regulation of its target gene, 8/March/2015, 22.34

Molecular therapy for Human Cancer: Roquin [RING finger and CCCH-type zinc finger domain-containing protein 1] increases the expression of tumor suppressor PDCD4 via down regulation of its target gene, 8/March/2015, 22.34 150 150

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Significance: This study suggests, for the first time, that Roquin, by down regulation of its target gene, it may increase the expression of metastasis suppressor PDCD4.  Thus, pharmacological formulations containing “Roquin activators” can be used in the treatment of human cancers.

To citeBoominathan,   Molecular therapy for Human Cancer: Roquin [RING finger and CCCH-type zinc finger domain-containing protein 1] increases the expression of  tumor suppressor PDCD4 via down regulation of its target gene, 8/March/2015, 22.34,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Undisclosed information: How Roquin increases the expression of PDCD4